At intermediate stages of prostate cancer, a considerable number of CXCL10+CD3+ T cells were located inside TLO (Figure 11B), and multiple epithelial cells were positive for CXCL10 in tumor areas (Figure 11F). This evidence concerns the gene CXCL10 and prostate carcinoma.